Dean Lloyd H 4

What Happened Dean Lloyd, a director of Surgery Partners, received a grant/award of 11,670 shares on June 5, 2026. The award is reported at a price of $13.71 per share, for a total reported value of $159,996. This was a compensatory grant (award), not an open-market purchase or sale.

Key Details

• Transaction date: June 5, 2026; price per share: $13.71; total reported value: $159,996.
• Shares acquired: 11,670 (transaction code A — award/grant).
• Shares owned after transaction: Not specified in the filing.
• Vesting: Footnote states the shares will vest on June 5, 2027.
• Filing: Form 4 was filed on June 9, 2026 (within the required filing window).

Context Grants like this are typically part of director compensation and include a vesting schedule; they do not represent an immediate cash purchase or sale of stock. Because the award vests in one year, the shares are subject to forfeiture until vesting and may not indicate near-term trading intent.